IMPORTANCE OF RADIOCHEMICAL PURITY OF RADIOLABELED DRUGS USED FOR DETERMINING PLASMA-PROTEIN BINDING OF DRUGS

被引：23

作者：

BJORNSSON, TD ^{[1
]}

BROWN, JE ^{[1
]}

TSCHANZ, C ^{[1
]}

机构：

[1] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710

来源：

关键词：

D O I：

10.1002/jps.2600701222

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1372 / 1373

页数：2

共 11 条

[1] ANTON AH, 1960, J PHARMACOL EXP THER, V129, P282
[2] BJORNSSON TD, 1979, J PHARMACOL EXP THER, V210, P316
[3] BORGA O, 1977, CLIN PHARMACOL THER, V22, P539
[4] COTHAM RH, 1975, CLIN PHARMACOL THER, V18, P535
[5] ADMINISTRATION OF HEPARIN CAUSES INVITRO RELEASE OF NON-ESTERIFIED FATTY-ACIDS IN HUMAN-PLASMA
GIACOMINI, KM
SWEZEY, SE
GIACOMINI, JC
BLASCHKE, TF
[J]. LIFE SCIENCES, 1980, 27 (09) : 771 - 780
[6] EFFECT OF PLASMA-PROTEIN BINDING OF DRUGS ON DURATION AND INTENSITY OF PHARMACOLOGICAL ACTIVITY
LEVY, G
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (08) : 1264 - 1265
[7] LEVY G, 1976, EFFECT DISEASE STATE, P137
[8] MCDEVITT DG, 1976, CLIN PHARMACOL THER, V20, P152
[9] WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377
[10] WOOD M, 1979, CLIN PHARMACOL THER, V25, P103